Clinical Trial Update: Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of IDP-118 lotion for plaque psoriasis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IDP-118 Lotion (IDP-118 lotion)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2020-01-27